Loading clinical trials...
Loading clinical trials...
This study targets two major risk factors for cancer; is designed to treat the behaviors on a population basis, using proactive recruitment strategies; intervenes on multiple behaviors simultaneously,...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Rhode Island
Collaborators
NCT05935241 · Sedentary Time, Insomnia, and more
NCT05047094 · Head and Neck Squamous Cell Carcinoma, Skin Cancer, and more
NCT07349940 · Skin Cancer Prevention, Melanoma In Situ, and more
NCT05702398 · Skin Cancer, Kidney Transplant Recipients
NCT07287917 · Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
University of Rhode Island
Kingston, Rhode Island
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions